Free Trial

Apogee Therapeutics (APGE) Earnings Date, Estimates & Call Transcripts

$47.52
-1.69 (-3.43%)
(As of 07/18/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 26Estimated
Actual EPS
(May. 13)
-$0.64 Missed By -$0.04
Consensus EPS
(May. 13)
-$0.60
Skip Charts & View Estimated and Actual Earnings Data

APGE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

APGE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Apogee Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.70)($0.70)($0.70)
Q2 20241($0.59)($0.59)($0.59)
Q3 20241($0.60)($0.60)($0.60)
Q4 20241($0.61)($0.61)($0.61)
FY 20244($2.50)($2.50)($2.50)
Q1 20251($0.63)($0.63)($0.63)
Q2 20251($0.64)($0.64)($0.64)
Q3 20251($0.65)($0.65)($0.65)
Q4 20251($0.67)($0.67)($0.67)
FY 20254($2.59)($2.59)($2.59)

APGE Earnings Date and Information

Apogee Therapeutics last released its quarterly earnings data on May 13th, 2024. The reported ($0.64) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.60) by $0.04. Apogee Therapeutics has generated ($5.25) earnings per share over the last year (($5.25) diluted earnings per share). Earnings for Apogee Therapeutics are expected to decrease in the coming year, from ($2.64) to ($2.96) per share. Apogee Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 26th, 2024 based off prior year's report dates.

Apogee Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/26/2024
(Estimated)
------- 
5/13/2024Q1 2024($0.60)($0.64)($0.04)($0.64)--
3/5/2024Q4 2023($0.45)($0.32)+$0.13($0.32)--
11/13/2023Q3 2023($0.43)($0.51)($0.08)($0.51)--
8/28/2023Q2 2023($2.49)($3.78)($1.29)($3.78)--

Apogee Therapeutics Earnings - Frequently Asked Questions

When is Apogee Therapeutics's earnings date?

Apogee Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 26th, 2024 based off last year's report dates. Learn more on APGE's earnings history.

Did Apogee Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Apogee Therapeutics (NASDAQ:APGE) missed the analysts' consensus estimate of ($0.60) by $0.04 with a reported earnings per share (EPS) of ($0.64). Learn more on analysts' earnings estimate vs. APGE's actual earnings.

How much profit does Apogee Therapeutics generate each year?

Apogee Therapeutics (NASDAQ:APGE) has a recorded net income of -$83.99 million. APGE has generated -$5.25 earnings per share over the last four quarters.

What is Apogee Therapeutics's EPS forecast for next year?

Apogee Therapeutics's earnings are expected to decrease from ($2.64) per share to ($2.96) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:APGE) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners